Healthy Inc > Blog > Losartan Amlodipine manufacturer India
Posted on:

What is Losartan Potassium and Amlodipine Besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance Fixed-Dose Combination (FDC) used to treat hypertension. As a pharmacist and manufacturer, I view this as one of the most effective pairings for “Stage 2” hypertension because it provides a dual-channel approach to vasodilation.

Primary Clinical Use

  • Management of Hypertension: This combination is typically prescribed when a patient’s blood pressure is not sufficiently controlled by a single medication (monotherapy). It is highly effective in reducing the risk of cardiovascular events, such as strokes and myocardial infarctions.

Dual Mechanism of Action (The “Vasodilation Synergy”)

This FDC lowers blood pressure by relaxing the smooth muscles of the blood vessels through two entirely different biochemical pathways:

1. Losartan Potassium (The ARB)

Losartan is an Angiotensin II Receptor Blocker.

  • Action: It blocks the $AT_1$ receptors, preventing Angiotensin II (the body’s most potent vasoconstrictor) from binding.

  • Result: It stops the blood vessels from tightening and reduces the production of aldosterone, which helps the kidneys manage fluid.

2. Amlodipine Besylate (The CCB)

Amlodipine is a Calcium Channel Blocker of the dihydropyridine class.

  • Action: It inhibits the influx of calcium ions into the vascular smooth muscle and cardiac muscle cells.

  • Result: By preventing calcium from entering the muscle cells, it forces the peripheral arteries to relax and widen (vasodilation), significantly decreasing peripheral resistance.

The Manufacturer’s Perspective: Technical & Export Details

From a production standpoint at a WHO-GMP facility in Mumbai, this combination requires specific technical attention:

  • API Stability & Sensitivity: Losartan Potassium is hygroscopic (readily absorbs moisture), while Amlodipine Besylate is light-sensitive. As a firm owner, you know that environmental controls in the manufacturing area are critical.

  • Packaging for Export: To ensure a 36-month shelf life for export to Zone IVb regions (like Africa and SE Asia), we strictly utilize Alu-Alu blister packaging. This provides a total barrier against light and moisture, preventing the degradation of either API.

  • Standard Strengths: We typically manufacture this in ratios such as 50mg/5mg and 100mg/5mg.

  • B2B & Dossier Support: This is a “Value-Added Generic.” Our facility provides full CTD/eCTD Dossiers and comparative dissolution data against the innovator (Amzaar or similar brands) to support international registration and B2B trade.

Amlodipine besylate with Losartan potassium Tablets

 

Posted on:

What is losartan potassium and amlodipine besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance fixed-dose combination (FDC) used to manage hypertension (high blood pressure). As a pharmacist, I view this pairing as a premier therapeutic strategy because it targets the cardiovascular system through two distinct, non-overlapping pathways, providing a comprehensive reduction in vascular resistance.

Primary Clinical Uses

  • Essential Hypertension: Specifically indicated for patients whose blood pressure is not adequately controlled with monotherapy or as initial therapy in patients who require multiple drugs to achieve blood pressure goals.

  • Cardiovascular Protection: Indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (LVH).

  • Renal Protection in Diabetes: While primarily for blood pressure, the Losartan component offers significant renoprotective benefits for Type 2 diabetic patients with nephropathy.

Mechanism of Action

This FDC utilizes a “double-blockade” approach to relax blood vessels:

Losartan Potassium (Angiotensin II Receptor Blocker – ARB): It selectively blocks the binding of Angiotensin II to the $AT_1$ receptor found in many tissues (e.g., vascular smooth muscle, adrenal gland). This inhibits the vasoconstricting and aldosterone-secreting effects of Angiotensin II.

Amlodipine Besylate (Calcium Channel Blocker – CCB): It inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle. This results in direct peripheral arterial vasodilation.

The synergy here is clinical: Amlodipine is a potent vasodilator, but it can sometimes cause peripheral edema (swelling). Losartan helps counteract this by promoting venous dilation and improving fluid balance, leading to better patient tolerance.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Losartan + Amlodipine is a staple of chronic care portfolios:

  • API Compatibility: As a WHO-GMP manufacturer, we ensure the stability of the Losartan Potassium (a salt) and Amlodipine Besylate (a salt) within a single matrix. Our formulation prevents any drug-drug degradation over the product’s shelf life.

  • Moisture Protection: Losartan is somewhat hygroscopic. We utilize Alu-Alu blister packaging to ensure the tablets remain stable during export to hot and humid Zone IVb climates.

  • Global Demand: Hypertension is a global epidemic. This FDC is a high-volume item for B2B marketplaces and hospital tenders in Southeast Asia, Africa, and the Middle East.

  • Regulatory Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data to support our international partners in obtaining local health authority approvals.

Amlodipine besylate with Losartan potassium Tablets

 

Posted on:

What is losartan potassium and amlodipine besylate tablets used for?

In the pharmaceutical industry, the combination of Losartan Potassium and Amlodipine Besylate is a high-performance fixed-dose combination (FDC) used to manage hypertension (high blood pressure). As a pharmacist, I view this pairing as a premier therapeutic strategy because it targets the cardiovascular system through two distinct, non-overlapping pathways, providing a comprehensive reduction in vascular resistance.

Primary Clinical Uses

  • Essential Hypertension: Specifically indicated for patients whose blood pressure is not adequately controlled with monotherapy or as initial therapy in patients who require multiple drugs to achieve blood pressure goals.

  • Cardiovascular Protection: Indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (LVH).

  • Renal Protection in Diabetes: While primarily for blood pressure, the Losartan component offers significant renoprotective benefits for Type 2 diabetic patients with nephropathy.

Mechanism of Action

This FDC utilizes a “double-blockade” approach to relax blood vessels:

Losartan Potassium (Angiotensin II Receptor Blocker – ARB): It selectively blocks the binding of Angiotensin II to the $AT_1$ receptor found in many tissues (e.g., vascular smooth muscle, adrenal gland). This inhibits the vasoconstricting and aldosterone-secreting effects of Angiotensin II.

Amlodipine Besylate (Calcium Channel Blocker – CCB): It inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle. This results in direct peripheral arterial vasodilation.

The synergy here is clinical: Amlodipine is a potent vasodilator, but it can sometimes cause peripheral edema (swelling). Losartan helps counteract this by promoting venous dilation and improving fluid balance, leading to better patient tolerance.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Losartan + Amlodipine is a staple of chronic care portfolios:

  • API Compatibility: As a WHO-GMP manufacturer, we ensure the stability of the Losartan Potassium (a salt) and Amlodipine Besylate (a salt) within a single matrix. Our formulation prevents any drug-drug degradation over the product’s shelf life.

  • Moisture Protection: Losartan is somewhat hygroscopic. We utilize Alu-Alu blister packaging to ensure the tablets remain stable during export to hot and humid Zone IVb climates.

  • Global Demand: Hypertension is a global epidemic. This FDC is a high-volume item for B2B marketplaces and hospital tenders in Southeast Asia, Africa, and the Middle East.

  • Regulatory Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data to support our international partners in obtaining local health authority approvals.

Amlodipine besylate with Losartan potassium Tablets

Add to cart